186 related articles for article (PubMed ID: 36566204)
1. Identification of hepatocellular carcinoma subtypes based on PcG-related genes and biological relevance with cancer cells.
Fu Y; Yang K; Wu K; Wang H; Li Q; Zhang F; Yang K; Yao Q; Ma X; Deng Y; Zhang J; Liu C; Qu K
Clin Epigenetics; 2022 Dec; 14(1):184. PubMed ID: 36566204
[TBL] [Abstract][Full Text] [Related]
2. Nuclear condensates of the Polycomb protein chromobox 2 (CBX2) assemble through phase separation.
Tatavosian R; Kent S; Brown K; Yao T; Duc HN; Huynh TN; Zhen CY; Ma B; Wang H; Ren X
J Biol Chem; 2019 Feb; 294(5):1451-1463. PubMed ID: 30514760
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic dysregulation in hepatocellular carcinoma: focus on polycomb group proteins.
Au SL; Ng IO; Wong CM
Front Med; 2013 Jun; 7(2):231-41. PubMed ID: 23620257
[TBL] [Abstract][Full Text] [Related]
4. Prognostic hub gene CBX2 drives a cancer stem cell-like phenotype in HCC revealed by multi-omics and multi-cohorts.
Meng Q; Zhou Q; Chen X; Chen J
Aging (Albany NY); 2023 Nov; 15(22):12817-12851. PubMed ID: 37980163
[TBL] [Abstract][Full Text] [Related]
5. A Noncanonical Function of Polycomb Repressive Complexes Promotes Human Cytomegalovirus Lytic DNA Replication and Serves as a Novel Cellular Target for Antiviral Intervention.
Svrlanska A; Reichel A; Schilling EM; Scherer M; Stamminger T; Reuter N
J Virol; 2019 May; 93(9):. PubMed ID: 30814291
[TBL] [Abstract][Full Text] [Related]
6. CBX2-mediated suppression of SIAH2 triggers WNK1 accumulations to promote glycolysis in hepatocellular carcinoma.
Xu Z; Wu Y; Yang M; Wei H; Pu J
Exp Cell Res; 2023 May; 426(1):113513. PubMed ID: 36780970
[TBL] [Abstract][Full Text] [Related]
7. Kicking against the PRCs - A Domesticated Transposase Antagonises Silencing Mediated by Polycomb Group Proteins and Is an Accessory Component of Polycomb Repressive Complex 2.
Liang SC; Hartwig B; Perera P; Mora-García S; de Leau E; Thornton H; de Lima Alves F; Rappsilber J; Yang S; James GV; Schneeberger K; Finnegan EJ; Turck F; Goodrich J
PLoS Genet; 2015 Dec; 11(12):e1005660. PubMed ID: 26642436
[TBL] [Abstract][Full Text] [Related]
8. EZH2 represses target genes through H3K27-dependent and H3K27-independent mechanisms in hepatocellular carcinoma.
Gao SB; Zheng QF; Xu B; Pan CB; Li KL; Zhao Y; Zheng QL; Lin X; Xue LX; Jin GH
Mol Cancer Res; 2014 Oct; 12(10):1388-97. PubMed ID: 24916103
[TBL] [Abstract][Full Text] [Related]
9. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
10. Single Nucleotide Polymorphisms of
Tan C; Bei C; Zhu X; Zhang Y; Qin L; Tan S
Biomed Res Int; 2019; 2019():6436825. PubMed ID: 31211140
[TBL] [Abstract][Full Text] [Related]
11. A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation.
Wang S; Alpsoy A; Sood S; Ordonez-Rubiano SC; Dhiman A; Sun Y; Jiao G; Krusemark CJ; Dykhuizen EC
Chembiochem; 2021 Jul; 22(13):2335-2344. PubMed ID: 33950564
[TBL] [Abstract][Full Text] [Related]
12. Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Jangal M; Lebeau B; Witcher M
Expert Opin Ther Targets; 2019 Jul; 23(7):565-578. PubMed ID: 31177918
[No Abstract] [Full Text] [Related]
13. A High-Density Map for Navigating the Human Polycomb Complexome.
Hauri S; Comoglio F; Seimiya M; Gerstung M; Glatter T; Hansen K; Aebersold R; Paro R; Gstaiger M; Beisel C
Cell Rep; 2016 Oct; 17(2):583-595. PubMed ID: 27705803
[TBL] [Abstract][Full Text] [Related]
14. Canonical PRC1 controls sequence-independent propagation of Polycomb-mediated gene silencing.
Moussa HF; Bsteh D; Yelagandula R; Pribitzer C; Stecher K; Bartalska K; Michetti L; Wang J; Zepeda-Martinez JA; Elling U; Stuckey JI; James LI; Frye SV; Bell O
Nat Commun; 2019 Apr; 10(1):1931. PubMed ID: 31036804
[TBL] [Abstract][Full Text] [Related]
15. Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer.
Clermont PL; Crea F; Chiang YT; Lin D; Zhang A; Wang JZ; Parolia A; Wu R; Xue H; Wang Y; Ding J; Thu KL; Lam WL; Shah SP; Collins CC; Wang Y; Helgason CD
Clin Epigenetics; 2016; 8():16. PubMed ID: 26877821
[TBL] [Abstract][Full Text] [Related]
16. Cbx2 stably associates with mitotic chromosomes via a PRC2- or PRC1-independent mechanism and is needed for recruiting PRC1 complex to mitotic chromosomes.
Zhen CY; Duc HN; Kokotovic M; Phiel CJ; Ren X
Mol Biol Cell; 2014 Nov; 25(23):3726-39. PubMed ID: 25232004
[TBL] [Abstract][Full Text] [Related]
17. The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma.
Gao SB; Xu B; Ding LH; Zheng QL; Zhang L; Zheng QF; Li SH; Feng ZJ; Wei J; Yin ZY; Hua X; Jin GH
J Hepatol; 2014 Oct; 61(4):832-9. PubMed ID: 24845612
[TBL] [Abstract][Full Text] [Related]
18. Downregulated Expression of Chromobox Homolog 7 in Hepatocellular Carcinoma.
Zhu X; Qin M; Li C; Zeng W; Bei C; Tan C; Zhang Y; Shi W; Kong J; Fu Y; Tan S
Genet Test Mol Biomarkers; 2019 May; 23(5):348-352. PubMed ID: 30990338
[No Abstract] [Full Text] [Related]
19. Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.
Vandamme J; Völkel P; Rosnoblet C; Le Faou P; Angrand PO
Mol Cell Proteomics; 2011 Apr; 10(4):M110.002642. PubMed ID: 21282530
[TBL] [Abstract][Full Text] [Related]
20. Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer.
Dong GJ; Xu JL; Qi YR; Yuan ZQ; Zhao W
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
